TrivarX Ltd: TrivarX Receives $1.03m R&D Tax Incentive
TrivarX Ltd: Change of Director's Interest Notice - Chris Ntoumenopoulos
TrivarX Ltd: Change of Director's Interest Notice - David Trimboli
TrivarX Ltd: Change of Director's Interest Notice - Tony Keating
TrivarX Ltd: Cleansing Notice
TrivarX Ltd: Notification regarding unquoted securities - TRI
TrivarX Ltd: Application for quotation of securities - TRI
TrivarX Ltd: Results of Annual General Meeting
TrivarX Ltd: Annual General Meeting - Chairman Update
TrivarX Ltd: New AI Tool Expands Patient Reach and Market Opportunities
TrivarX Ltd: September 2024 Quarterly Activities Report and Appendix 4C
TrivarX Ltd: Proposed issue of securities - TRI
TrivarX Ltd: Letter to Shareholders & Notice of AGM & Proxy Form
TrivarX Ltd: Notice of AGM and Closing Date for Director Nominations
TrivarX Ltd: Initial Director's Interest Notice - John Mathias
TrivarX Ltd: Company Secures R&D Loan Facility
TrivarX Ltd: TrivarX Appoints Leading US Healthcare Executive to Board
TrivarX Ltd: TrivarX Requests Pre-Submission Meeting with US FDA
TrivarX Ltd: Appendix 4G
TrivarX Ltd: Corporate Governance Statement